Glenmark Pharmaceuticals Ltd soars 0.2%, gains for fifth straight session

Glenmark Pharmaceuticals Ltd is quoting at Rs 1979, up 0.2% on the day as on 12:44 IST on the NSE. The stock is up 27.57% in last one year as compared to a 5.44% jump in NIFTY and a 2.05% jump in the Nifty Pharma.

Glenmark Pharmaceuticals Ltd is up for a fifth straight session today. The stock is quoting at Rs 1979, up 0.2% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.14% on the day, quoting at 26010.15. The Sensex is at 85166.94, down 0.12%. Glenmark Pharmaceuticals Ltd has gained around 5.89% in last one month.

Meanwhile, Nifty Pharma index of which Glenmark Pharmaceuticals Ltd is a constituent, has gained around 0.68% in last one month and is currently quoting at 22808.7, down 0.42% on the day. The volume in the stock stood at 1.52 lakh shares today, compared to the daily average of 11.36 lakh shares in last one month.

The benchmark December futures contract for the stock is quoting at Rs 1982.6, down 0.03% on the day. Glenmark Pharmaceuticals Ltd is up 27.57% in last one year as compared to a 5.44% jump in NIFTY and a 2.05% jump in the Nifty Pharma index.

Related Posts

AbbVie loses patent plea for Hep C drug

New Delhi: The Indian Patent Office has refused to grant a secondary patent to AbbVie for its blockbuster Hepatitis C drug combination glecaprevir/pibrentasvir, sold globally under the brand name Maviret.…

GSK’s Calpol a well-known trademark: High Court

New Delhi: In a relief to UK-headquartered GlaxoSmithKline Pharmaceuticals (GSK), the Delhi High Court has declared its pain and fever medicine ‘Calpol’ as a well-known trademark that has acquired extensive…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

AbbVie loses patent plea for Hep C drug

AbbVie loses patent plea for Hep C drug

GSK’s Calpol a well-known trademark: High Court

GSK’s Calpol a well-known trademark: High Court

3 arrested for allegedly posing as doctors using forged MBBS degrees

3 arrested for allegedly posing as doctors using forged MBBS degrees

Commissioner FDA reviews enforcement measures

Commissioner FDA reviews enforcement measures

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer